Forte Biosciences Inc (FBRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access FBRX quarterly Balance Sheets →
Examining balance sheet movements between Forte Biosciences Inc and Dec 31 2021 reveals how Dec 31 2025 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent76.96
Short-term Investments, Total0.00
Cash & Short-term Investments76.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current4.32
Total Current Assets80.59
Equipment/Property/Plant Net0.24
Tax Assets, Noncurrent39.49
Other Assets, Noncurrent0.00
Total Assets82.78
Liabilities
Accounts Payable, Current AC9.99
Accrued Liabilities, Current AC10.76
Taxes Payable0.63
Total Current Liabilities20.75
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent1.04
Total Liabilities21.79
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock284.35
Retained Earnings / Accumulated Deficit-223.37
Accumulated Other Comprehensive Income0.00
Other Equity0.00
Common Stockholder's Equity60.99
Total Stockholder's Equity60.99
Liabilities & Stockholder's Equity82.78
4 historic quarters locked

Sign in to unlock the full Forte Biosciences Inc balance sheet history.

About Forte Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-134498

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License